FDA Inspection 1216509 — Oklahoma Blood Institute-North Oklahoma City Donor Center

Oklahoma Blood Institute-North Oklahoma City Donor Center — FEI 1641066

The FDA completed an inspection of Oklahoma Blood Institute-North Oklahoma City Donor Center on August 16, 2023 in Yukon, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Yukon, OK (United States)